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Abstract: Preconception care and lifestyle behaviours significantly influence health outcomes of
women and future generations. A cross-sectional survey of Australian women in preconception,
stratified by pregnancy planning stage (active planners (currently trying to conceive) vs. non-active
planners (pregnancy planned within 1–5 years)), assessed health behaviours and their alignment to
preconception care guidelines. Overall, 294 women with a mean (SD) age of 30.7 (4.3) years were
recruited and 38.9% were overweight or obese. Approximately half of women (54.4%) reported
weight gain within the previous 12 months, of which 69.5% gained ≥ 3kg. The vast majority of
women (90.2%) were unaware of reproductive life plans, and 16.8% over the age of 25 had not
undertaken cervical screening. Of active planners (n = 121), 47.1% had sought medical/health advice
in preparation for pregnancy and 81.0% had commenced supplementation with folic acid, iodine or
a preconception multivitamin. High-risk lifestyle behaviours including cigarette smoking (7.3%),
consumption of alcohol (85.3%) and excessive alcohol consumption within three months (56.3%), were
frequently reported in women who were actively trying to conceive. Results indicate that women
who are actively planning a pregnancy require support to optimise health and lifestyle in preparation
for pregnancy to improve alignment with current preconception care recommendations.
Keywords: preconception; health behaviours; pregnancy planning; women’s health; clinical
care guidelines
1. Introduction
The health status and behaviours of prospective parents before conception, known as the
preconception period, is important for the health of women and future generations [1,2]. Initiating
strategies to optimise health and lifestyle behaviours during preconception is vital, as some of the
most important mechanisms for development and factors affecting birth outcomes occur in the very
early stages of pregnancy, often before women are aware they are pregnant or commence antenatal
care [3,4]. There are many modifiable health behaviours that can negatively impact outcomes during
pregnancy that are difficult to change in the short term [5], and, therefore, addressing these warrants
early intervention, during preconception. These include a balanced diet and regular moderate-intensity
exercise consistent with recommendations [6,7], weight management, cessation of cigarette smoking,
alcohol and recreational drug use, and treatment of sexually transmitted infections (STIs). All of these
may also optimise fertility, thereby increasing the likelihood of natural conception [2,5].
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The Royal Australian College of General Practitioners (RACGP) Guidelines for Preventative
Activities in General Practice [8] recommend a range of preconception care (PCC) strategies, consistent
with several other international PCC guidelines [9,10]. Major components of PCC include risk
assessment (12), education and health promotion, and medical and psychosocial interventions [11]
to enhance knowledge, attitudes and behaviours and improve the health status of prospective
parents [10,12]. Understanding whether women seek PCC, what areas of PCC are addressed, as well
as their health behaviours during this time, is therefore important, to identify deviation between
individual health behaviours and PCC recommendations. This, in turn, can inform and refine PCC
recommendations, focus policy and enable targeted PCC strategies where required.
While information is available about the uptake of antenatal care by Australian women [13], little
is known about behaviour before pregnancy. Of the available evidence, the majority are retrospective
studies of pregnant women [5,14,15]. These studies preclude insight from women who may be planning
a pregnancy but do not conceive and are also susceptible to recall bias [16–18]. Further, the majority of
research relates to a limited number of health behaviours, predominantly folic acid supplementation,
alcohol consumption and cigarette smoking [5,19,20]. A comprehensive and holistic understanding of
preconception health and behaviours in women currently planning a pregnancy is lacking. To address
these fundamental gaps, this cross-sectional study aims to examine health behaviours of women during
preconception, in accordance with Australian PCC recommendations [8]. The secondary aim is to
compare the results of women at different stages of family planning, to evaluate any differences in
behaviour patterns.
2. Materials and Methods
2.1. Study Design
A cross-sectional questionnaire completed by Australian women in preconception or
interconception (between pregnancies).
2.2. Health Setting, Recruitment and Participants
The Australian healthcare system is government-supported via ‘Medicare’, which provides
universal, free or low-cost care to Australian citizens and residents (and others eligible) across most
health services. Private health insurance, paid by the individual, enables choice of hospital and/or
provider outside of the public system. Insurance is typically characterised by waiting periods for
hospital cover, including pregnancy and birth cover with a 12-month average waiting period before
some, or all, of the cost of hospital treatment as a patient is covered. Women of reproductive age who
have private health insurance pregnancy therefore provide a unique cohort through which to explore
preconception health, before conception actually occurs.
In this study, women were recruited via partnership with a large Australian private healthcare
insurance provider, Medibank Private Limited (MPL). Eligible women included those aged between
18–40 years, who had joined or upgraded their health insurance in the previous 12 months to include
pregnancy and birth cover, were not pregnant at the time of completing the questionnaire and indicated
they were planning a pregnancy within the next five years. Those who indicated they were planning
a pregnancy beyond five years into the future, were unsure of, or not, planning a pregnancy or had
completed their family were excluded.
A co-developed invitation for participation was emailed by MPL to all eligible women explaining
the study and the voluntary nature of participation. Women opted in to the study, providing implied
consent, by following an electronic link and completing the anonymous online questionnaire.
2.3. Ethics
Ethics approval for this study was obtained by the Monash Health (RES-17-0000-087A) and
Monash University (Project no. 10370) Human Research Ethics Committees.
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2.4. The Questionnaire
The questionnaire was adapted from existing tools to assess women’s pregnancy planning
and related health behaviours, risk perception and knowledge. Detailed information about this
questionnaire has been published previously [21] and the questions analysed in the current study are
provided as supplementary material. It was developed in consultation with multidisciplinary health
and medical expertise across obstetrics, public health, social science, dietetics, exercise physiology and
endocrinology, with cognitive interviewing and consumer testing performed as previously reported [15].
Information gathered within the questionnaire was aligned with Australian PCC recommendations [8].
This included awareness of a reproductive life plan (a personalised set of goals about pregnancy
intention, timing and spacing of intended pregnancies, and associated physical, mental and sexual
health considerations [22]); reproductive history; genetic history and screening for genetic conditions;
general physical assessment (BMI, cervical screening, STI screening and dental examination history);
screening for infectious diseases/immunisation status; folic acid and iodine supplementation; nutrition
and exercise; psychosocial factors and substance use (tobacco, alcohol and recreational drugs) [8,23].
General physical assessment, including cervical and STI screening, were analysed in accordance with
current Australian guidelines which recommend cervical screening every five years from 2017 for
women aged 25–74 years of age that are sexually active (or after two years if last test was prior to
2017, followed by every five years if results are normal) [24]. STI screening recommendations include
opportunistic screening of sexually active women under 29 years of age and annual screening for
high-risk groups, such as Aboriginal and Torres Strait Islander people, sex workers and women who
inject drugs [8].
2.5. Stage of Pregnancy Planning
To establish stage of pregnancy planning, women were asked ‘are you planning a pregnancy in
the future?’. Women who selected ‘yes, I am currently trying to conceive’ or ‘yes, within 1 year’ were
classified as ‘active planners’. Those who answered ‘yes, within 5 years’ were classified as ‘non-active
planners’.
2.6. Demographics
Socio-economic status was estimated according to participant’s post code, using the deciles
in the Australian Socio-Economic Indexes for Areas (SEIFA) Index of Relative Socio-economic
Disadvantage [25]. Deciles 1–3 were classified as higher-level disadvantage, 4–7 as moderate-level
disadvantage and decile 8–10 as lower-level disadvantage. Rural/remote or urban locality was
determined by post code using the Rural and Remote Postcode List [26].
2.7. Reproductive Health, Family Planning and Genetic Health
Women were asked what form of contraception was used ‘every time’, ‘most of the time’,
‘sometimes’ or ‘never’ in the last six months when engaging in sexual intercourse. Women could select
multiple types of contraception and could select multiple frequencies of use. Selections of ‘every time’
and/or ‘most of the time’ were classified as regular use, and ‘sometimes’ and ‘never’ were captured as
non-regular use. Previous and current use of fertility treatment was assessed by the question, ‘have
you or your partner been treated for, or are currently undergoing treatment for infertility?’, (yes/no).
2.8. Actions to Prepare for Pregnancy
Women were asked if they were currently taking actions to improve their health in preparation for
pregnancy, including the following: taking folic acid, iodine, pre-pregnancy multivitamins (analysed
individually and combined as a composite) or vitamin D; trying to cut down or stop smoking, cut
down or stop drinking alcohol, improve diet, improve exercise level or improve sleep patterns; seeking
medical/health advice; not doing any action listed; or taking some other action.
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2.9. Lifestyle Behaviours and Modifiable Risk Factors
Current and/or recent behaviour relating to alcohol consumption, recreational drug use and
smoking was collected. Women were asked to record their average alcohol consumption from
Monday–Thursday and Friday–Sunday, per week, for the previous three months, which was collated
into a weekly average. The women were also asked to provide the number of times they had consumed
more than four standard drinks in one single occasion (excessive drinking) in the past three months:
‘I don’t remember/I don’t know’; or ‘I had stopped drinking alcohol because I was trying to get
pregnant’ were provided as additional response options. The cohort were asked if they had ever taken
recreational drugs; those who answered ‘yes’ were then asked when the last time they took recreational
drugs was. Smoking status was recorded by asking ‘are you currently smoking’, (yes/no). Participants
could choose not to respond to questions regarding cigarette smoking or drug use by selecting ‘prefer
not to answer’.
Self-reported weight and height were collected and used to calculate BMI (weight/height
(m2)), which was classified according to the World Health Organization definitions: underweight
(≤18.49 kg/m2); normal weight (18.50–24.99 kg/m2) (herein referred to as healthy BMI); overweight
(25.00–29.99 kg/m2); and obese (≥ 30.00kg/m2) [27]. Weight-related behaviours were evaluated,
including self-weighing behaviour (daily, weekly, monthly (regular weigher) or occasionally, never
(non-regular weigher)), weight maintenance behaviours (maintain or lose weight), and weight gain in
the previous 12 months (yes, no or unsure; if yes, how much weight gain: 1–2kg, 3–5kg or 6 + kg).
2.10. Statistical Analysis
Data analysis was performed using IBM SPSS Statistics version 25 (Armonk, New York, NY, USA).
Descriptive statistics were tested for skewness by using the Shapiro–Wilk test and were presented
as mean and standard deviation (SD) for normally distributed continuous variables, and median
and interquartile range (IQR) for skewed continuous variables. Frequencies and percentages were
presented for categorical variables. The Kruskal–Wallis Test, Mann–Whitney U and the chi-squared
test (χ2 tests) were used to compare the characteristics of women, stratified by pregnancy intention.
A subanalysis was performed for fertility treatment, cervical screening, weight-related actions, weight
gain within the previous 12 months and amount of weight gain. To perform subanalyses variables
were stratified to explore the characteristics of those within the cohort who reported a response of
interest. All p-values presented are two-tailed; p < 0.05 was considered statistically significant. Where
a significant p-value was identified in a multiple comparison, the Bonferroni correction was used to




In total, 4870 eligible women were invited to participate (2104 did not open the original email
and were therefore treated as not contactable); of those who opened the email, 23.8% opened the
questionnaire and 18.2% (n = 504) attempted it. Ninety-two women reported being currently pregnant
and 118 selected a pregnancy intention that did not meet the inclusion criteria, leaving 294 women who
met the inclusion criteria for the current study. Overall, the mean age was 30.7 (4.3) years and median
BMI was 23.7 (20.1, 26.8) kg/m2. Overall, 41% (n = 121) of women were classified as actively planning
for pregnancy while 59% (n = 173) were not actively planning for pregnancy. Women who were actively
planning for pregnancy were more likely to be married/de facto (97.8% vs. 90.7%, p = 0.04) compared
with non-active planners, with no further significant differences in demographic characteristics found
between the two groups (Table 1).
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Table 1. Participant characteristics stratified by pregnancy intention.
Characteristic All (n = 294) Active Planners(n = 121)
Non-Active Planners
(n = 173) p-Value
Age (years) Mean (SD) n = 195 n = 89 n = 106
30.7 (4.3) 31.4 (4.4) 30.2 (4.1) 0.35
BMI (kg/m2) Median (IQR) n = 193 n = 88 n = 105
23.7 (20.1, 26.8) 24.2 (20.8, 27.7) 23.1 (20.3, 26.0) 0.05
Country of birth n = 197 n = 90 n = 107
Australia 135 (68.5%) 56 (62.2%) 79 (73.8%)
0.08Outside Australia 62 (31.5%) 34 (37.8%) 28 (26.2%)
Education n = 196 n = 89 n = 107
School Only 10 (5.1%) 6 (6.7%) 4 (3.7%)
0.18Certificate/Diploma/Apprenticeship 69 (35.2%) 36 (40.5%) 33 (30.8%)
University 117 (59.7%) 47 (52.8%) 70 (65.4%)
Employment n = 196 n = 89 n = 107
Employed 184 (93.9%) 86 (96.6%) 98 (91.6%)
0.14Unemployed 12 (6.1%) 3 (3.4%) 9 (8.4%)
Area of residence n = 192 n = 87 n = 105
Urban 158 (82.3%) 73 (83.9%) 20 (19.0%)
0.29Rural/remote 33 (17.7%) 14 (16.1%) 85 (81.0%)
SEFIA n = 191 n = 86 n = 105
Higher-level disadvantage 18 (9.4%) 8 (9.3%) 10 (9.5%)
0.98Moderate-level disadvantage 59 (30.9%) 26 (30.2%) 33 (31.4%)
Lower-level disadvantage 114 (59.7%) 52 (60.5%) 62 (59.0%)
Annual household income (AUD) n = 196 n = 89 n = 107
<$40,000 8 (4.1%) 4 (4.5%) 4 (3.7%)
0.74
$41,000–$64,999 17 (8.7%) 9 (10.1%) 8 (7.5%)
$65,000–$80,000 24 (12.2%) 8 (9.0%) 16 (15.0%)
>$81,000 135 (68.9%) 62 (69.7%) 73 (68.2%)
Prefer not to answer 12 (6.1%) 6 (6.7%) 6 (5.6%)
Relationship Status n = 196 n = 89 n = 107
Married/De facto 184 (93.9%) 87 (97.8%) 97 (90.7%)
0.04Unmarried 12 (6.1%) 2 (2.3%) 10 (9.3%)
Total n for each variable may vary based on the total number of responses.
Compared with key demographic characteristics from available 2016 Australian Census
information [29] across ~3.7 million women aged 18–40 years; 68.9% of our cohort reported a
higher annual household income than the population median (~$74,446 AUD/year). The frequency of
those reporting unemployment (6.1%) was comparable to Australian females aged 15 years and over
(6.7% unemployed). We recruited a comparable proportion of women born overseas to the overall
Australian population (31.5% vs. 26.7%), while a smaller proportion of our cohort lived in rural/remote
areas (17.7% compared to 29.0%).
3.2. Reproductive Health, Family Planning and Genetic Factors
Approximately 90% of women overall were not aware of a reproductive life plan and approximately
~30% reported having a previous pregnancy. Thirty percent of active planners (the participant or
their partner) reported currently or previously undertaking fertility treatment compared to 4.1% of
non-active planners (p < 0.001). A subanalysis showed that those who reported use of fertility treatment
were of a similar age (31.7 (4.0) vs. 30.6 (4.3) years p = 0.81) with a higher median BMI (25.7 (20.5, 30.9)
vs. 23.3 (20.4, 26.2) kg/m2, p < 0.05) compared to those not reporting fertility treatment and a higher
proportion were overweight or obese women (58.1% vs. 35.1%, p < 0.05). All other outcomes for
reproductive health, family planning and genetic factors are displayed in Table 2.
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Table 2. Reproductive health, actions and awareness, stratified by pregnancy intention.
Factor or Action All (n = 294) Active Planners(n = 121)
Non-Active Planners
(n = 173) p-Value
Awareness of reproductive life
plan n = 255 n = 110 n = 145
Yes 25 (9.8%) 10 (9.1%) 15 (10.3%) 0.74
Previous pregnancy n = 57 n = 31 n = 26
Yes 20 (35.1%) 12 (38.7%) 8 (30.8%) 0.53
Regular contraception choice
No contraception n = 232 n = 103 n = 129 <0.00187 (37.5%) 65 (63.1%) 22 (17.1%)
Withdrawal
n = 213 n = 89 n = 124
<0.0141 (19.2%) 9 (10.1%) 32 (25.8%)
Barrier
n = 223 n = 92 n = 131
<0.00162 (27.8%) 14 (15.2%) 48 (36.6%)
Hormonal
n = 233 n = 95 n = 138
<0.00185 (25.8%) 12 (12.6%) 73 (52.9%)
Fertility treatment (previous or
current treatment of participant or
their partner)
n = 255 n = 110 n = 145
Yes 40 (15.7%) 34 (30.9%) 6 (4.1%) <0.001
Personal/family history of genetic
condition n = 199 n = 90 n = 109
Yes 40 (20.1%) 19 (21.1%) 21 (19.3%)
0.95No 119 (59.8%) 53 (58.9%) 66 (60.6%)
Unsure 40 (20.1%) 18 (20.0%) 22 (20.2%)
Tested for genetic conditions n = 40 n = 19 n = 21
Yes 23 (57.5%) 10 (53.6%) 13 (61.9%)
0.84No 15 (37.5%) 8 (42.1%) 7 (33.3%)
Unsure 2 (5.0%) 1 (5.3%) 1 (4.8%)
Total n for each variable may vary based on the total number of responses.
3.3. General Physical Health, Medical Screening and Immunisation Status
General physical health characteristics, uptake of medical screening, routine health checks and
testing and immunisation status are presented in Table 3, with no significant differences found between
active and non-active planners. Approximately 17.0% of women over 25 years had never undertaken
cervical screening for cancer prevention. A subanalysis comparing women those who had commenced
screening (n = 159) with those who had not (n = 33), found no significant differences in demographic
characteristics, with the exception of SEIFA classification, which indicated they were more likely to
reside in an area of higher-level disadvantage (25.0% vs. 5.2%, p = 0.002). Twelve (n = 12) of those
unscreened and aged over 25 years reported they had sought medical/health advice to prepare for
pregnancy, and 6.1% had been tested for an STI within six months.
3.4. Actions to Prepare for Pregnancy, Unhealthy Lifestyle Behaviours and Modifiable Risk Factors
Women actively planning for pregnancy were more likely to report folic acid (75.2% vs. 30.6%,
p < 0.001), iodine (29.8% vs. 16.2%, p = 0.01), pre-pregnancy (44.6% vs. 17.9%, p < 0.001) and/or vitamin
D supplementation (38.9% vs. 22.5%, p = 0.003) compared with non-active planners (Table 4).
Overall, 6.6% were currently smoking, 85.3% had consumed alcohol in the previous three months
and 59.0% indicated they had engaged in excessive drinking within the previous three months. Active
planners were significantly more likely to report alcohol cessation in the previous three months in
preparation for pregnancy, compared with women not actively planning (19.8% vs. 5.3%, p = 0.01). Yet,
overall, active planners reported a similar median number of alcoholic drinks per week (4.0 (1.0, 7.0)
vs. 3.0 (0.5, 5.5)) compared with women not actively planning (p = 0.35).
J. Clin. Med. 2020, 9, 1701 7 of 14
Table 3. General physical health and screening, stratified by pregnancy intention.
Factor or Action All (n = 294) Active Planners(n = 121)
Non-Active Planners
(n = 173) p-Value
BMI category n = 193 n = 88 n = 105
Underweight 7 (3.6%) 4 (4.5%) 3 (2.9%)
0.43
Healthy 111 (57.5%) 45 (51.1%) 66 (62.9%)
Overweight 39 (20.2%) 21 (23.9%) 19 (18.1%)
Obese 36 (18.7%) 18 (20.5%) 17 (16.2%)
Undertaken cervical screening/pap
smear n = 197 n = 90 n = 107
Yes 159 (80.7%) 73 (81.1%) 86 (80.4%)
0.97No (aged, >25yrs) 33 (16.8%) 15 (16.7%) 18 (16.8%)
No (aged, ≤25yrs) 5 (2.5%) 2 (2.2%) 3 (2.8%)
STI test (within 6 months) n = 197 n = 90 n = 107
Yes 57 (28.9%) 31 (34.4%) 26 (24.3%) 0.12
Dental Check Up (within 12
months) n = 252 n = 110 n = 142
Yes 181, (71.8%) 81, (73.6%) 100, (70.4%) 0.06
Currently experiencing gum/teeth
problem n = 252 n = 110 n = 142
Yes 32 (12.7%) 15 (13.6%) 17 (12.0%) 0.69
Up-to-date immunisation n = 197 n = 90 n = 107
Measles Mumps Rubella (MMR) 152 (77.2%) 72 (80.0%) 80 (74.8%) 0.38
Hepatitis B 139 (70.6%) 65 (72.2%) 74 (69.2%) 0.64
Chicken Pox (Varicella) 124 (62.9%) 55 (61.1%) 69 (59.8%) 0.63
Tetanus/Diphtheria/Pertussis
(whooping cough) 156 (79.2%) 71 (78.9%) 85 (79.4%) 0.92
Influenza 101 (51.3%) 46 (51.1%) 55 (51.4%) 0.97
None of the above 18 (9.1%) 7 (7.8%) 11 (10.3%) 0.54
Unsure 4 (2.0%) 1 (1.1%) 3 (2.8%) 0.40
Total n for each variable may vary based on the total number of responses.
Approximately half of all women (54.4%) reported gaining weight in the previous 12 months,
with 50.5% of these women reporting an increase of 3–5kg or more, and 19.1% reporting an increase
of 6kg or more. Weighing habits, weight gain in previous 12 months, amount of weight gain and
weight-related actions between the two groups did not differ significantly.
3.5. Subanalysis of Weight Behaviour and Weight Gain
Most women who reported weight gain in the previous 12 months were a healthy BMI (57.1%),
while 21.0% were overweight, 21.0% were obese and 1.0% were underweight. The majority of those
who reported a weight gain of 6kg or more within 12 months were obese (65.0%) or overweight (20.0%),
with 15.0% a healthy BMI. Smaller weight increases of 1–2kg and 3–5kg in the previous year were most
prevalent in women of a healthy BMI (81.3% and 58.5%, respectively), followed by those overweight
(12.5% and 3.1%, respectively) and obese (26.4 and 15.1%, respectively).
Seventy-six percent of women who reported that they were currently trying to maintain a healthy
weight were a healthy BMI, while 6.7% were underweight, 15.6% were overweight and 2.2% were
obese. Of these, 38.9% reported gaining weight in the previous 12 months, while 52.2% had not and
8.9% were unsure.
The majority of women trying to lose weight reported weight gain in the previous 12 months
(68.9%) and were an unhealthy BMI (34.4% obese, 25.8% overweight and 1.1% underweight) compared
with 38.7% who were a healthy BMI. Most of those who reported no attempt to maintain nor lose
weight were a healthy BMI (70.0% vs. 30.0% overweight/obese). Sixty percent of all women taking no
weight-related actions reported weight gain within the previous 12 months.
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Table 4. Actions to prepare for pregnancy, unhealthy lifestyle behaviours and modifiable risk factors,
stratified by pregnancy intention.
Factor or Action All (n = 294) Active Planners(n = 121)
Non-active Planners
(n = 173) p-Value
Current actions to prepare for pregnancy n = 294 n = 121 n = 173
Supplement use:
Taking folic acid 144 (49.0%) 91 (75.2%) 53 (30.6%) <0.001
Taking iodine 64 (21.8%) 36 (29.8%) 28 (16.2%) 0.01
Taking a pre-pregnancy supplement 85 (28.9%) 54 (44.6%) 31 (17.9%) <0.001
Taking folic acid/iodine/pre-pregnancy
supplement * 155 (52.7%) 98 (81.0%) 57 (33.0%) <0.001
Taking vitamin D 86 (29.3%) 47 (38.9%) 39 (22.5%) <0.01
Taking other supplements 40 (13.6%) 14 (11.6%) 26 (15.0%) 0.40
Diet:
Improving diet 190 (64.6%) 77 (63.6%) 113 (65.3%) 0.77
Physical activity:
Increasing exercise 176 (59.9%) 67 (55.4%) 109 (63.0%) 0.19
Psychosocial:
Improving sleeping patterns/decreasing
stress 78 (26.5%) 27 (22.3%) 51 (29.5%) 0.17
Healthcare:
Seeking medical/health advice 119 (40.5%) 57 (47.1%) 62 (35.8%) 0.05
Other:
Trying to stop/decrease smoking 18 (6.1%) 7 (5.8%) 11 (6.4%) 0.84
Trying to stop/decrease drinking alcohol 74 (25.2%) 43 (35.5%) 31 (17.9%) <0.01
Not doing any of the above 26 (8.8%) 5 (4.1%) 21 (12.1%) 0.02
Smoking status n = 252 n = 110 n = 142
Yes, current smoker 17 (6.6%) 8 (7.3%) 9 (6.3%)
0.92Never smoked/quit smoking 235 (91.8%) 100 (90.9%) 131 (92.3%)
Prefer not to answer 4 (1.6%) 2 (1.8%) 2 (1.4%)
Consumed alcohol in previous 3 months n = 225 n = 95 n = 130
Yes 192 (85.3%) 81 (85.3%) 111 (85.4%) 0.98
Excessive drinking n = 227 n = 96 n = 131
One or more times 134 (59.0%) 54 (56.3%) 80 (61.1%)
<0.01 **
Nil 41 (18.1%) 14 (14.6%) 27 (20.6%)
Unsure 26 (11.5%) 9 (9.4%) 17 (13.0%)
Stopped drinking for pregnancy 26 (11.5%) 19 (19.8%) ** 7 (5.3%) **
Average alcoholic drinks per week in
past 3 months. Median (IQR) n = 225 n = 92 n = 133
3.0 (0.0, 6.0) 4.0 (1.0, 7.0) 3.0 (0.5, 5.5) 0.35
Recreational drug use n = 248 n = 108 n = 140
Yes, within 1 month 13 (5.2%) 5 (4.6%) 8 (4.3%)
0.95
Yes, within 1 year 13 (5.2%) 7 (6.5%) 6 (4.3%)
Yes, but not within 1 year 48 (19.4%) 21 (19.4%) 27 (19.3%)
Never 169 (68.1%) 73 (67.6%) 96 (68.6%)
Prefer not to answer 5 (2.0%) 2 (1.9%) 3 (2.1%)
Weighing habits n = 193 n = 88 n = 105
Regular 93 (48.2%) 47 (53.4%) 46 (43.8%)
0.18Irregular 100 (51.8%) 41 (46.6%) 59 (56.2%)
Weight gain in previous 12 months n = 193 n = 88 n = 105
Yes 105 (54.4%) 43 (48.9%) 62 (59.1%)
0.37No 74 (38.3%) 38 (43.2%) 36 (34.3%)
Unsure 14 (7.3%) 7 (8.0%) 7 (6.7%)
Amount weight gain in previous 12
months n = 105 n = 43 n = 62
1–2 kg 32 (30.5%) 14 (32.6%) 18 (29.0%)
0.793–5 kg 53 (50.5%) 20 (46.5%) 33 (53.2%)
6 kg or more 20 (19.0%) 9 (20.9%) 11 (17.7%)
Weight related actions (trying to..) n = 254 n = 110 n = 144
Maintaining a healthy weight 116 (45.7%) 53 (48.2%) 63 (43.8%)
0.73Lose weight 125 (49.2%) 51 (46.4%) 74 (51.4%)
Neither of the above 13 (5.1%) 6 (5.5%) 7 (4.9%)
* Participants who selected one or more of the following options: (currently) taking folic acid/folate/Blackmores
I-Folic/iodine/multivitamin for pre-pregnancy or (currently) taking other action (and listed pregnancy/pre-pregnancy
multivitamin or similar). ** Significant difference (p = 0.001) identified here after Bonferroni correction. Total n for
each variable may vary based on the total number of responses.
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4. Discussion
We report that less than half of women planning a pregnancy had sought medical or health
advice in preparation for pregnancy, and, of those that did, missed opportunities for important
components of PCC existed. While uptake of cervical screening and up-to-date immunisation was
relatively high, there was no difference between groups, with one in five active planners indicating
they have never completed cervical screening and similar or greater proportions not immunised
adequately for pregnancy. The intention to cease modifiable high-risk behaviours such as cigarette
smoking and alcohol consumption was greater in those actively planning, yet the incidence and
frequency of associated behaviours did not vary from those not actively planning a pregnancy. We
also report increased weight gain in our cohort, emphasising the burden of accelerated progression to
obesity in young, reproductive-aged women. Overall, despite some favourable areas of preconception
health and pregnancy planning, including supplementation use, our results highlight several areas of
preconception health warranting improved awareness, support and resources for women planning
a pregnancy.
Our results show that less than half of women planning a pregnancy had sought health or medical
advice as part of their pregnancy planning behaviour. This could be reflective of previous research
demonstrating that women in preconception do not view themselves as a distinct group in need of
healthcare [30,31]. It is plausible that women may plan for pregnancy individually, only engaging with
their primary healthcare provider if difficulty in conceiving occurs [32]. The vast majority of active
planners reported efforts to improve diet and increase exercise and had commenced preconception
supplementation in line with national recommendations and consistent with previous Australian
studies [19,33,34]. Our results indicate increased confidence in adopting self-managed behaviours and
potentially lower awareness of aspects of PCC warranting health professional engagement [32,35],
including cervical screening, immunisation and genetic testing, emphasising the need for targeted
preconception health promotion in these areas in women planning a pregnancy.
Here, we found that approximately 1 in 5 eligible women had not commenced cervical screening.
Interestingly, ~40.0% of these had sought medical/health advice to prepare for pregnancy, presenting a
missed opportunity to initiate screening. Barriers for cervical screening are most commonly related
to embarrassment, not acting on an intention to be screened, fear of pain and fear of results [36].
It is possible that women who had reported seeking advice and had not previously had a cervical
screening test were provided with information but did not ultimately complete screening. Here, we
found those that had not commenced screening were more likely to reside in areas of higher-level
disadvantage compared with those who had performed screening. Given that engagement with a
healthcare provider did not vary by screening status, this is likely not reflective of reduced access
to healthcare or resources, with other contributory factors not captured by our survey potentially
explaining results found. Similarly, 1 in 5 women or above were not adequately immunised for
pregnancy and 50.0% of those with a known family history of a genetic condition had not been screened.
We also report that approximately 30.0% of our cohort had undertaken an STI test within six months,
in line with previous research [37]. Given uptake of all of screening types was similar in both groups,
there is opportunity to improve these preventive health measures in primary care settings in all women
preconception, irrespective of pregnancy planning. Barriers to PCC reported by GPs include lack
of awareness of pregnancy intention and lack of presentation during preconception [38], mirroring
results found here. Taken together, results concur with previous research highlighting the need to
develop strategies that both encourage women into self-directed partnerships with their primary
healthcare provider whilst also addressing barriers health providers experience for enhanced health
communication overall [23].
Our findings indicate that women planning a pregnancy are not adhering to recommendations
advising abstinence of alcohol during preconception [8], with just 11.5% reporting that they had
stopped drinking, comparable to previous findings [39]. We found average weekly alcohol intake was
comparable irrespective of planning status, potentially indicating complacency and/or ambivalence
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towards drinking in women actively planning for pregnancy. This could be due to the influence of
individual and social factors as well as the normalisation of alcohol intake in women presenting as
facilitators [18]. This highlights the need for strategies that encourage cessation of alcohol consumption
when actively attempting to conceive given the discrepancy between intention and behaviour reported
here. This could include leveraging off recent legislative changes on the introduction of warning labels
on alcoholic beverages in Australia [40] and elsewhere [41].
Achieving and maintaining a healthy weight is highlighted as crucial in international
evidence-based guidelines for preconception, pregnancy and post-pregnancy health [9]. Here, we
report that ~55.0% of our cohort reported weight gain in the last 12 months, with 69.5% of these
reporting an increase of three or more kilograms within the previous year. Even modest weight gain
increases cardiovascular and chronic disease risk [42], whilst simultaneously contributing to obesity
risk and conversion to higher BMI categories. Further, pregnancy is a recognised high-risk window
for excessive gestational weight gain and postpartum weight retention [43,44]. This reaffirms the
critical need for early intervention, prior to pregnancy, for weight gain prevention and/or weight
loss where required, given the associated pregnancy and future health risk for mother and child [45].
Overall, approximately half of all women were currently trying to lose weight, and, encouragingly, the
majority of active planners reported they had improved their diet and exercise behaviours to prepare
for pregnancy, potentially reflective of enhanced motivation to ensure optimised health in pregnancy,
as previously reported [46].
Reproductive and fertility behaviours varied, potentially in line with women’s pregnancy planning
intentions. Women not actively planning a pregnancy were more likely to report hormonal and barrier
contraceptive use, which is positive, both decreasing the likelihood of an unplanned pregnancy and
enabling opportunities for PCC. Interestingly, one quarter of non-active planners reported using the
withdrawal method regularly, potentially indicating complacency and/or lack of awareness, given
this is recognised as one of the least effective forms of contraception with a ~20.0% failure rate [47,48].
Conversely, current or previous assisted fertility treatment was reported by a higher proportion of
women actively planning for pregnancy compared to non-active planners. There was no difference in
age in those who had engaged in fertility treatment compared with those who had not; however, there
were higher proportions of overweight or obesity overall. One in six Australian couples experience
fertility problems [49], in line with international estimates [50]. Most fertility treatment in Australia
is provided in the private health system, and the high rate of fertility treatment reported by active
planners in this study may reflect increased likelihood of commencing private health insurance to
access treatment (as reported previously) as well as the overall higher socioeconomic status (SES) of
participants [51]. Fertility treatment reported in non-active planners is likely reflective of previous
treatment; however, this cannot be delineated from current use due to the survey structure. Similarly,
we were unable to explore causes of infertility and associated treatment overall.
Strengths and Limitations
Our rigorously developed questionnaire assessed an extensive range of health and lifestyle
behaviours in accordance with the majority of national PCC recommendations [21]. Our stratification
by stage of pregnancy planning strengthens the understanding of PCC uptake by enabling differences
in behaviour to be observed. While the cross-sectional design of our study can explore associations,
we are unable to confirm causal relationships and inferential statistics were not possible.
Our cohort consisted of women who had private health insurance, which may limit the
generalisability of our results to other populations owing to an overall higher socio-demographic profile.
The private health system uniquely provides an opportunity to explore preconception behaviours
before conception due to waiting periods, of typically 12-months, before hospital-based healthcare
claims can be made. Whilst this study group are of a higher SES, ~50.0% of Australian women
of reproductive age have private health insurance and 26.0% birth in private hospitals [13]; hence,
J. Clin. Med. 2020, 9, 1701 11 of 14
our results are relevant to a significant proportion of Australian women, further emphasized by
comparability with Australian population census data.
5. Conclusions
Our results demonstrate significant divergence from PCC recommendations in women planning
for pregnancy, with several areas of preconception health that warrant improved health promotion.
While women appear to be more receptive to self-managed aspects of preconception health, including
supplementation, weight management and intention to cease higher-risk behaviours including alcohol
intake, we found minimal variation in behaviour compared with women not actively planning a
pregnancy. Given the potential for evidence-based PCC to optimise fertility and reduce adverse
maternal and child outcomes, efforts are required to improve PCC knowledge, awareness and uptake
through strengthened partnerships between women and their healthcare providers. Future research
would benefit from extension into other populations as well as prospective studies examining causal
associations between preconception health behaviours and associated outcomes during pregnancy.
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